Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC

Catequentinib improves PFS vs placebo in advanced or metastatic leiomyosarcoma

ASCO 2025: Metastatic breast cancer treatment highlights

ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer

Disparities in mammogram screening amongst LGBTQ+ populations

Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential thrombocythaemia

QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBC

Upfront modified FOLFOXIRI plus panitumumab improves OS in RAS/BRAF wild-type mCRC

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer

New MOAs in prostate cancer treatment - what’s next?

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers

Long-term infusion of dinutuximab beta improves survival in high-risk neuroblastoma